NCT07254442已完成不适用
Investigation of the Impact of Medications Used in COVID-19 Treatment and COVID-19 Vaccine on Hearing
Zonguldak Bulent Ecevit University1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2021年12月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 90
- 试验地点
- 1
- 主要终点
- Pure tone and high frequency hearing thresholds
研究概览
简要总结
Investigation of the Impact of Medications Used in COVID-19 Treatment and COVID-19 Vaccine on Hearing
详细描述
This study aims to investigate the impact of medications containing the active ingredients hydroxychloroquine and favipiravir on the auditory system, as well as to examine the effect of COVID-19 on hearing and its potential relationship with medication use and COVID-19 vaccine dose.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 35 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Age between 18 and 35 For the Medication group: Having had COVID-19 and using COVID-19 medications For the Non-Medication group: Having had COVID-19 and not using COVID-19 medications For the Control group: Having never had COVID-19
排除标准
- •Previously diagnosed with hearing loss Use of ototoxic medications other than those specified Pathology detected during tympanometric evaluation or otoscopic examination Chronic disease Family history of hearing loss History of meningitis Neurological disorders Acute or chronic ear infection Admission to intensive care
结局指标
主要结局
Pure tone and high frequency hearing thresholds
时间窗: December, 2021-February 2022
Transient evoked otoacoustic emissions - Signal/noise ratio
时间窗: December, 2021-February 2022
Distortion product otoacoustic emissions- signal/noise ratio
时间窗: December, 2021-February 2022
次要结局
未报告次要终点
研究者
Azize Arzu KÖROĞLU KOÇYİĞİT
Audiologist, Lecturer
Zonguldak Bulent Ecevit University
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Drug-Drug Interactions and Prescription Appropriateness in COVID-19 ICU PatientsCOVID 19 virus identified,CTRI/2022/09/045611ESIC Medical College and Hospital191
Unknown
不适用
Effects on the Qt Interval of COVID-19 Coronavirus InfectionIntensive Care PatientsCoronavirus InfectionNCT04422535Matilde Zaballos80
终止
不适用
Efficacy of COVID-19 Vaccination in Patients With Multiple Sclerosis Treated With Immune Modulating MedicationMultiple SclerosisNCT04796584Providence Health & Services20
已完成
3 期
ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19Covid19NCT04843761National Institute of Allergy and Infectious Diseases (NIAID)473
已完成
3 期
ACTIV-3: Therapeutics for Inpatients With COVID-19Covid19NCT04501978National Institute of Allergy and Infectious Diseases (NIAID)2,753